Bretylium abolishes neurotransmitter release without necessarily abolishing the nerve terminal action potential in sympathetic terminals

British Journal of Pharmacology

Volumn 153, Issue 4, 2008, Pages 831-839

  Brain, K L ^a   Cunnane, T C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Bretylium; Calcium; Confocal; Mouse; Sympathetic; Vas deferens

Indexed keywords

ADENOSINE TRIPHOSPHATE; BRETYLIUM TOSYLATE; CALCIUM; FORMALDEHYDE; GLUTARALDEHYDE; NEUROPEPTIDE Y;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG MECHANISM; FLUORESCENCE; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE ENDING; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; SYMPATHETIC NERVE; VAS DEFERENS;

ACTION POTENTIALS; ADENOSINE TRIPHOSPHATE; ANIMALS; BRETYLIUM COMPOUNDS; CALCIUM SIGNALING; CATECHOLAMINES; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; NEUROPEPTIDE Y; NEUROTRANSMITTER AGENTS; PRESYNAPTIC TERMINALS; SYMPATHETIC NERVOUS SYSTEM; SYNAPTIC TRANSMISSION; TIME FACTORS; VAS DEFERENS;

EID: 39449098223     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707623     Document Type: Article

References (39)

1. Al-Zuhair A, Gosling JA, Dixon JS (1975). Observations on the structure and autonomic innervation of the guinea-pig seminal vesicle and ductus deferens. J Anat 120: 81-93.
2. Björklund A, Falck B, Lindvall O, Svensson LA (1973). New aspects on reaction mechanisms in the formaldehyde histofluorescence method for monoamines. J Histochem Cytochem 21: 17-25.
3. Boura AL (1997). The actions of bretylium: adrenergic neurone blocking and other effects. Br J Pharmacol 120: S162-S165.
4. Boura AL, Green AF (1962). Comparison of bretylium and guanethidine: tolerance, and effects on adrenergic nerve function and responses to sympathomimetic amines. Br J Pharmacol Chemother 19: 13-41.
5. Boura ALA, Green AF (1959). The actions of bretylium: adrenergic neurone blocking and other effects. Br J Pharmacol 14: 536-548.
6. Brain KL, Bennett MR (1997). Calcium in sympathetic varicosities of mouse vas deferens during facilitation, augmentation and autoinhibition. J Physiol 502: 521-536.
7. 2+ transients in the mouse vas deferens. J Physiol 553: 627-635.
8. 2+ transients in mouse vas deferens. J Physiol 541: 849-862.
9. Brock JA, Cunnane TC (1988). Studies on the mode of action of bretylium and guanethidine in post-ganglionic sympathetic nerve fibres. Naunyn Schmiedeberg's Arch Pharmacol 338: 504-509.
10. Carvalho TL, Kempinas WG, Favaretto AL (1993). Morphometric evaluation of the rat testis, epididymis and vas deferens following chemical sympathectomy with guanethidine. Anatomischer Anzeiger 175: 453-457.
11. Cottee LJ, Lavidis NA, Bennett MR (1996). Spatial relationships between sympathetic varicosities and smooth muscle cells in the longitudinal layer of the mouse vas deferens. J Neurocytol 25: 413-425.
12. Dahlström A, Häggendal J, Hökfelt T (1966). The noradrenaline content of the varicosities of sympathetic adrenergic nerve terminals in the rat. Acta Physiologica Scandinavica 67: 289-294.
13. Falck B, Hillarp NA, Thieme G, Torp A (1962). Fluorescence of catecholamines and related compounds condensed with formaldehyde. J Histochem Cytochem 10: 348-354.
14. Furness JB, Costa M, Llewellyn-Smith IJ (1987). Localization of monoamines by aldehyde-induced fluorescence in the peripheral nervous system. In: Steinbusch HWM (ed). Monoaminergic Neurons: Light Microscopy and Ultrastructure, vol. 10. Wiley Interscience: Chichester, pp 1-25.
15. Furness JB, Heath JW, Costa M (1978). Aqueous aldehyde (Faglu) methods for the fluorescence histochemical localization of catecholamines and for ultrastructural studies of central nervous tissue. Histochemistry 57: 285-295.
16. Haeusler G, Haefely W, Huerlimann A (1969). On the mechanism of the adrenergic nerve blocking action of bretylium. Naunyn Schmiedebergs Arch Pharmakol 265: 260-277.
17. 2+ transients evoked by nerve stimulation in rat urinary bladder smooth muscle. J Physiol 564: 201-212.
18. 2+ transients in varicosities in the mouse vas deferens. Br J Pharmacol 135: 1845-1850.
19. Jackson VM, Trout SJ, Brain KL, Cunnane TC (2001). Characterization of action potential-evoked calcium transients in mouse postganglionic sympathetic axon bundles. J Physiol 537: 3-16.
20. Jones ME, Spriggs TL (1975). Noradrenaline and motor transmission in the vas deferens of the mouse. Br J Pharmacol 53: 323-331.
21. Koganezawa T, Ishikawa T, Fujita Y, Yamashita T, Tajima T, Honda M et al. (2006). Local regulation of skin blood flow during cooling involving presynaptic P2 purinoceptors in rats. Br J Pharmacol 148: 579-586.
22. 2+ transients during neurogenic contractions of rat mesenteric small arteries. J Physiol 549: 801-808.
23. 2+ transients (jCaTs) in rat small arteries. Circ Res 91: 454-456.
24. Lavidis NA, Bennett MR (1993). Sympathetic innervation of the surface of the mouse vas deferens. J Auton Nerv Syst 45: 87-100.
25. Maxwell RA, Wastila WB (1977). Adrenergic neuron blocking drugs. In: Gross F (ed). Handbook of Experimental Pharmacology, vol. 39. Springer Verlag: Berlin, pp 161-261.
26. Merrillees NCR, Burnstock G, Holman ME (1963). Correlation of fine structure and physiology of the innervation of smooth muscle in the guinea-pig vas deferens. J Cell Biol 19: 529-550.
27. Mitchell JR, Oates JA (1970). Guanethidine and related agents. I. Mechanism of the selective blockade of adrenergic neurons and its antagonism by drugs. J Pharm Exp Ther 172: 100-107.
28. Nakamura T (1979). Application of the Faglu method (Furness et al.) for the histochemical demonstration of catecholamine to the cryostat method. Acta Histochem Cytochem 12: 182.
29. 3H] noradrenaline release in chick sympathetic neurons. J Physiol 437: 201-220.
30. Richardson KC (1966). Electron microscopic identification of autonomic nerve endings. Nature 210: 756.
31. Risley P, Skrepetos CN (1964). Histochemical distribution of cholinesterases in the testis, epididymis and vas deferens of the rat. Anat Rec 148: 231-241.
32. Ross SB, Gosztonyi T (1975). On the mechanism of the accumulation of 3H-bretylium in peripheral sympathetic nerves. Naunyn Schmiedebergs Arch Pharmacol 288: 283-293.
33. Sjöstrand NO (1965). The adrenergic innervation of the vas deferens and the acessory male genital organs. Acta Physiologica Scandinavica 257: S1-82.
34. Song ZM, Brookes SJ, Gibbins IL, Costa M (1994). NADPH-diaphorase and other neuronal markers in nerves and ganglia supplying the guinea-pig vas deferens. J Auton Nerv Syst 48: 31-43.
35. Stjärne L, Lundberg JM, Astrand P (1986). Neuropeptide Y - a cotransmitter with noradrenaline and adenosine 5′-triphosphate in the sympathetic nerves of the mouse vas deferens? A biochemical, physiological and electropharmacological study. Neuroscience 18: 151-166.
36. Taxi J (1965). Contribution a l'étude des connexions des neurones moteurs du système nerveux autonomie. Annales des sciences naturelles Zoologie et biologie animale 7: 413-674.
37. Ubink R, Hokfelt T (2000). Neuropeptide Y expression in Schwann cell precursors. Glia 32: 71-83.
38. Ventura S, Bavetta S, Milner P, Ralevic V, Burnstock G (1998). Nitric oxide synthase is co-localized with vasoactive intestinal polypeptide in postganglionic parasympathetic nerves innervating the rat vas deferens. Neuroscience 83: 607-616.
39. Yamauchi A, Burnstock G (1969). Post-natal development of the innervation of the mouse vas deferens. A fine structural study. J Anat 104: 17-32.